HC Wainwright & Co. Maintains Buy on Gamida Cell, Lowers Price Target to $5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Vernon Bernardino has maintained a Buy rating on Gamida Cell (NASDAQ:GMDA) but has reduced the price target from $11 to $5. This adjustment reflects a change in valuation but still suggests confidence in the company's potential.

November 15, 2023 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gamida Cell's stock may experience some volatility due to the lowered price target from $11 to $5 by HC Wainwright, despite maintaining a Buy rating.
While the reduction in price target could be seen as a negative signal, potentially leading to a short-term dip in stock price, the maintenance of a Buy rating indicates that the analyst still sees long-term value in the company. This mixed message may result in a neutral short-term impact as the market digests both pieces of information.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100